Castle Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.48M Sell
3,508
-86
-2% -$34.3K 0.46% 50
2026
Q2
$1.3M Buy
3,594
+181
+5% +$62K 0.39% 56
2026
Q1
$1.2M Sell
3,413
-38
-1% -$13.5K 0.39% 58
2025
Q4
$1.13M Sell
3,451
-675
-16% -$214K 0.37% 56
2025
Q3
$1.16M Buy
4,126
+114
+3% +$33.1K 0.39% 59
2025
Q2
$1.12M Buy
4,012
+184
+5% +$52.1K 0.41% 57
2025
Q1
$1.19M Buy
3,828
+147
+4% +$43.4K 0.47% 51
2024
Q4
$959K Buy
3,681
+177
+5% +$52.5K 0.38% 58
2024
Q3
$1.13M Buy
3,504
+2,207
+170% +$722K 0.45% 52
2024
Q2
$405K Buy
+1,297
New +$381K 0.19% 90
2022
Q4
– Sell
-461
Closed -$104K – 127
2022
Q3
$104K Sell
461
-19
-4% -$4.61K 0.06% 146
2022
Q2
$117K Buy
+480
New +$118K 0.07% 133

Other funds holding AMGN

Castle Wealth Management's AMGN Position: Q3 2026 in Review

Castle Wealth Management reduced its Amgen (AMGN) stake by 2.4% in Q3 2026, selling an estimated $34.3K and leaving 3,508 shares worth $1.48M. The position accounts for 0.46% of the portfolio, ranked #50.

Castle Wealth Management first reported a position in AMGN in Q2 2022 and has held it in 12 quarters since. 3,253 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Castle Wealth Management held 3,508 shares of Amgen worth $1.48M as of Q3 2026.
  • Castle Wealth Management sold 86 Amgen shares in Q3 2026, an estimated $34.3K.
  • Amgen made up 0.46% of Castle Wealth Management's portfolio in Q3 2026, its #50 holding.
  • Castle Wealth Management first reported a position in Amgen in Q2 2022 and has held it in 12 quarters since.
  • 3,253 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Castle Wealth Management's 13F filing for Q3 2026, filed 10 Nov 2026.